Prevalence of obstructive sleep apnoea following head and neck cancer treatment: A cross-sectional study

Oral Oncology ◽  
2006 ◽  
Vol 42 (1) ◽  
pp. 107-113 ◽  
Author(s):  
Willem Nesse ◽  
Aarnoud Hoekema ◽  
Boudewijn Stegenga ◽  
Johannes H. van der Hoeven ◽  
Lambert G.M. de Bont ◽  
...  
2017 ◽  
Vol 27 (2) ◽  
pp. 556-562 ◽  
Author(s):  
Kanako Ichikura ◽  
Aya Yamashita ◽  
Taro Sugimoto ◽  
Seiji Kishimoto ◽  
Eisuke Matsushima

Medicina ◽  
2020 ◽  
Vol 56 (8) ◽  
pp. 399
Author(s):  
Massimo Ralli ◽  
Flaminia Campo ◽  
Diletta Angeletti ◽  
Eugenia Allegra ◽  
Antonio Minni ◽  
...  

Background and objectives: Obstructive sleep apnoea (OSA) is clinically defined by signs of daytime sleepiness and objective measures of disordered breathing during sleep. The literature is still controversial on the incidence and aetiology of OSA secondary to head and neck cancer treatment. The aim of this systematic review is to evaluate and discuss the prevalence of OSA in patients treated with surgery and/or chemo/radiotherapy for head and neck cancer. Materials and methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search was performed on May 2020 using the MEDLINE database, Scopus, and Google Scholar. The searches were conducted using combinations of the following terms: head and neck cancer, OSA, radiotherapy, chemotherapy, partial laryngectomy, laryngeal cancer, neoplasm, tumour, carcinoma, and oropharyngeal cancer. Results: Our results suggest that head and neck cancer patients have a higher incidence of OSA (59.78%) compared to the general population; differences may occur based on the type of treatment. Conclusions: Clinicians should recognise the higher prevalence of OSA in patients treated for head and neck cancer and should consider a comprehensive sleep history as part of the evaluation and management of these patients. Further research is needed to evaluate the exact prevalence, aetiology, and correct management of OSA after treatment for head and neck cancer.


2021 ◽  
pp. 1-8
Author(s):  
Obed Solís-Martínez ◽  
Karolina Álvarez-Altamirano ◽  
Diana Cardenas ◽  
Yanelly Trujillo-Cabrera ◽  
Vanessa Fuchs-Tarlovsky

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Corinne Vannimenus ◽  
◽  
Hélène Bricout ◽  
Olivier Le Rouzic ◽  
François Mouawad ◽  
...  

2021 ◽  
Vol 11 (2) ◽  
pp. 215-218
Author(s):  
Manali Deb Barma ◽  
Meignana Arumugham Indiran ◽  
Pradeep Kumar R ◽  
Arthi Balasubramaniam ◽  
M.P Santhosh Kumar

2020 ◽  
Vol 11 (4) ◽  
pp. 7811-7816
Author(s):  
Sushanthi S ◽  
Meignana Arumugham Indiran ◽  
Pradeep Kumar Rathinavelu ◽  
Arthi Balasubramaniam

Individuals often encounter psychological distress after a diagnosis of cancer, especially head and neck cancer (HNC). Worries regarding restricted functions, facial disfigurement, waiting time for investigation and duration of hospital stay for treatment make them feel awful. Often this feeling goes unnoticed and is underestimated. We aimed to assess the prevalence of the dreadful feeling in terms of anxiety and depression in newly diagnosed head and neck cancer patients. A cross-sectional study was conducted in two cancer-treating institutions in South India. About 357 freshly diagnosed HNC patients participated in the study. Pre-validated Hospital Anxiety and Depression Scale (HADS) was used to assess the anxiety and depression levels. Descriptive statistics was done to report socio-demographic, clinical variables and mean scores. Independent t-test and correlation test were done for comparison and association, respectively. Mean depression score for males and females was 11.481, 11.865, respectively. Mean anxiety score for males was 11.708 and 11.792 for females. There was a strong positive correlation between depression and anxiety score (0.864) among patients. There was no statistically significant difference in the mean anxiety and depression scores among gender, socioeconomic status, marital status and cancer stages (p>0.05). Newly diagnosed HNC patients had an abnormal level of anxiety and depression, which needs special attention and care during treatment for a better outcome.


2020 ◽  
Vol 40 (5) ◽  
pp. 338-342
Author(s):  
Federico Leone ◽  
Giulia Anna Marciante ◽  
Chiara Re ◽  
Alessandro Bianchi ◽  
Fabrizio Costantini ◽  
...  

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Tseganesh Asefa Yifru ◽  
Sezer Kisa ◽  
Negalign Getahun Dinegde ◽  
Niguse Tadele Atnafu

Abstract Objective Impaired swallowing is a primary medical concern in head and neck cancer (HNC) patients. Swallowing therapy and supportive care to relieve swallowing problems among HNC patients are recommended. However, no data shows the effect of dysphagia on the quality of life (QoL) among Ethiopian patients. This cross-sectional study aimed to assess swallowing function and its impact on QoL. Results The sample included 102 HNC patients who visited oncology clinics at Tikur Anbessa Specialized Hospital. Majority were male (53.90%), employed (70.6%), single (57.80%), and completed some level of formal education (66.60%) with a mean age of 42.58 years (SD ± 14.08). More than half of the patients (69.6%) medical expenses were covered by the government. Most were suffering from advanced stage HNC (59.80%), squamous cell carcinoma (62.70%), and the most prevalent tumor location was nasopharynx (40.20%). The mean MDADI score was 53.29 (SD ± 15.85). Being female, low income, suffering from laryngeal cancer, advanced tumor, and undergoing a single modality therapy were crucial determinants of poor QoL related to swallowing problems. It is recommended to assess swallowing related QoL of patients using a validated tool and be included in treatment protocols.


Sign in / Sign up

Export Citation Format

Share Document